AB

Asim Barman

Active Director Director DIN 08245995
DIN 08245995 First appointment Oct 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2018
Shareholding value •••• Premium profile

About Asim Barman

Data last updated:

Asim Barman is a Director at Arsenal Pharmaceuticals Private Limited (since 2018). The company operates in Pharma. Arsenal Pharmaceuticals Private Limited reported revenue of ₹50.2 Lakh (FY 2025).

DIN 08245995
Primary Designation Director
Industry Pharma
First Appointment 01 Oct 2018
Oldest Company Age 8 yrs
Largest company Arsenal Pharmaceuticals Private Limited · ₹50.2 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Oct 20182018₹50.2 Lakh (FY 2025)Active

Board colleagues of Asim Barman

NameDINCompanyDesignation
Sushil Thakur08245994Arsenal Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Arsenal Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Asim Barman

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Asim Barman

Asim Barman currently holds 1 directorship: Arsenal Pharmaceuticals Private Limited (Director, since 01 Oct 2018, revenue ₹50.2 Lakh (FY 2025)).

Asim Barman was first appointed on 01 Oct 2018 as Director at Arsenal Pharmaceuticals Private Limited.

The current boards of Asim Barman's companies include Sushil Thakur (Arsenal Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available